Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Wesseling-Perry

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Pediatric Nephrology (Berlin, Germany)|October 16, 2012
Bone disease in pediatric chronic kidney diseaseKatherine Wesseling-Perry
Current Osteoporosis Reports|February 2, 2015
Defective skeletal mineralization in pediatric CKDKatherine Wesseling-Perry
The American Journal of Pathology|February 25, 2014
The BRC canopy: an important player in bone remodelingKatherine Wesseling-Perry
Kidney International|May 15, 2017
Osteocyte dysfunction and renal osteodystrophy: not just calcium and phosphorus anymoreKatherine Wesseling-Perry
Pediatric Nephrology (Berlin, Germany)|December 17, 2009
FGF-23 in bone biologyKatherine Wesseling-Perry
Pediatric Nephrology (Berlin, Germany)|March 12, 2011
CKD-MBD after kidney transplantationKatherine Wesseling-Perry, Justine Bacchetta
Bone|October 20, 2012
The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complicationsKatherine Wesseling-Perry, Harald Jüppner
Pediatric Nephrology (Berlin, Germany)|September 24, 2017
Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney diseaseNadine Khouzam, Katherine Wesseling-Perry
Current Opinion in Nephrology and Hypertension|May 22, 2009
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?Katherine Wesseling-Perry, Isidro B Salusky
Pediatric Nephrology (Berlin, Germany)|February 6, 2013
Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in childrenKatherine Wesseling-Perry, Isidro B Salusky
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Pediatric Nephrology (Berlin, Germany)|October 16, 2012
Bone disease in pediatric chronic kidney diseaseKatherine Wesseling-Perry
Current Osteoporosis Reports|February 2, 2015
Defective skeletal mineralization in pediatric CKDKatherine Wesseling-Perry
The American Journal of Pathology|February 25, 2014
The BRC canopy: an important player in bone remodelingKatherine Wesseling-Perry
Kidney International|May 15, 2017
Osteocyte dysfunction and renal osteodystrophy: not just calcium and phosphorus anymoreKatherine Wesseling-Perry
Pediatric Nephrology (Berlin, Germany)|December 17, 2009
FGF-23 in bone biologyKatherine Wesseling-Perry
Pediatric Nephrology (Berlin, Germany)|March 12, 2011
CKD-MBD after kidney transplantationKatherine Wesseling-Perry, Justine Bacchetta
Bone|October 20, 2012
The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complicationsKatherine Wesseling-Perry, Harald Jüppner
Pediatric Nephrology (Berlin, Germany)|September 24, 2017
Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney diseaseNadine Khouzam, Katherine Wesseling-Perry
Current Opinion in Nephrology and Hypertension|May 22, 2009
Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?Katherine Wesseling-Perry, Isidro B Salusky
Pediatric Nephrology (Berlin, Germany)|February 6, 2013
Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in childrenKatherine Wesseling-Perry, Isidro B Salusky
Pageof 7